OpenAlex
PricingAboutJobs
Log inGet started
Work

Phase I and pharmacokinetic study of tirapazamine (SR 4233) administered every three weeks.

PubMed

Year: 1997
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: S Senan, R Rampling, M A Graham, P Wilson, H Robin, N Eckardt, N Lawson, A McDonald, R von Roemeling, P Workman, S B Kaye
Institution: University of Glasgow
Language: English

Topic: Bioactive Compounds and Antitumor Agents
Subfield: Toxicology
Field: Pharmacology, Toxicology and Pharmaceutics
Domain: Life Sciences
Keywords: tirapazamine, SR 4233, bioreductive agents, ototoxicity, dose-limiting toxicity, pharmacokinetics, plasma AUC, dose proportionality, hypoxic tumor cells, cisplatin combination chemotherapy, single-agent chemotherapy
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W1684733013
FWCI: 3.947
Cites: 35
Cited by: 50
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security